Amalgamated Bank Sells 911 Shares of Avantor, Inc. (NYSE:AVTR)

Amalgamated Bank trimmed its stake in shares of Avantor, Inc. (NYSE:AVTR) by 2.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 37,159 shares of the company’s stock after selling 911 shares during the quarter. Amalgamated Bank’s holdings in Avantor were worth $788,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Versant Capital Management Inc increased its holdings in Avantor by 2,003.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. boosted its stake in Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after buying an additional 1,391 shares during the period. TFO Wealth Partners LLC grew its position in Avantor by 203,100.0% during the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock worth $46,000 after buying an additional 2,031 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in Avantor in the 1st quarter worth about $93,000. Finally, ORG Partners LLC raised its holdings in shares of Avantor by 5,773.0% in the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after acquiring an additional 5,773 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AVTR. Robert W. Baird boosted their price objective on Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Morgan Stanley increased their price target on shares of Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. TD Cowen increased their target price on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Stifel Nicolaus lifted their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Finally, Citigroup downgraded Avantor from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $30.00 to $23.00 in a research report on Wednesday, July 10th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $27.60.

Avantor Price Performance

Shares of NYSE:AVTR opened at $25.83 on Friday. The firm’s 50 day simple moving average is $25.45 and its two-hundred day simple moving average is $24.38. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company has a market capitalization of $17.55 billion, a P/E ratio of 66.92, a P/E/G ratio of 2.71 and a beta of 1.32. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $28.00.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 5.28% and a return on equity of 12.40%. Research analysts expect that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.